<DOC>
	<DOCNO>NCT02233686</DOCNO>
	<brief_summary>The purpose study determine effectiveness XEN-D0501 placebo reduce daytime cough frequency patient chronic obstructive pulmonary disease ( COPD ) . The effectiveness XEN-D0501 placebo reduce capsaicin cough response , objective 24-hour cough frequency , hourly change cough frequency , cough severity ( via visual analogue scale [ VAS ] ) , urge cough ( via VAS ) , global rating change scale , Clinical COPD Questionnaire ( CCQ ) , Leicester Cough Questionnaire ( LCQ ) , St George 's Respiratory Questionnaire ( SGRQ-C ) evaluate .</brief_summary>
	<brief_title>A Study Assess Efficacy XEN-D0501 Reducing Cough Frequency Patients With COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>Male/female subject age 40 COPD Clinically significant medical history Abnormal laboratory result , ECGs vital sign</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>